PR013/#1503  Toripalimab combined with bevacizumab and chemotherapy as first-line treatment for refractory, recurrent or metastatic cervical cancer: a single-arm, open-label, phase II TRIA

Chen Li; Peng Peng; Hairong Yao; Dantong Liu; Yonglan He; Shikai Liu; Ninghai Cheng; Dongyan Cao; Yang Xiang

doi:10.1136/ijgc-2023-IGCS.56

Article info

Featured Posters: Poster Rounds with the Professors

AS03. Cervical cancer

PR013/#1503 Toripalimab combined with bevacizumab and chemotherapy as first-line treatment for refractory, recurrent or metastatic cervical cancer: a single-arm, open-label, phase II TRIA

Free

Authors

Chen Li Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Obstetrics and Gynecology, Beijing, China PubMed articles Google scholar articles
Peng Peng Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Obstetrics and Gynecology, Beijing, China PubMed articles Google scholar articles
Hairong Yao Cangzhou Central Hospital, Department of Gynecology, Cangzhou, China PubMed articles Google scholar articles
Dantong Liu Cangzhou Central Hospital, Department of Gynecology, Cangzhou, China PubMed articles Google scholar articles
Yonglan He Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Radiology, Beijing, China PubMed articles Google scholar articles
Shikai Liu Cangzhou Central Hospital, Department of Gynecology, Cangzhou, China PubMed articles Google scholar articles
Ninghai Cheng Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Obstetrics and Gynecology, Beijing, China PubMed articles Google scholar articles
Dongyan Cao Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Obstetrics and Gynecology, Beijing, China PubMed articles Google scholar articles
Yang Xiang Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Obstetrics and Gynecology, Beijing, China PubMed articles Google scholar articles

Citation

Li C, Peng P, Yao H, et al

PR013/#1503 Toripalimab combined with bevacizumab and chemotherapy as first-line treatment for refractory, recurrent or metastatic cervical cancer: a single-arm, open-label, phase II TRIA

International Journal of Gynecologic Cancer 2023;33:A37.

Publication history

First published November 7, 2023.

Online issue publication

November 07, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password